Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBANDRONIC ACID for Osteoporosis postmenopausal: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 116 adverse event reports in the FDA FAERS database where IBANDRONIC ACID was used for Osteoporosis postmenopausal.

Most Reported Side Effects for IBANDRONIC ACID

Side Effect Reports % Deaths Hosp.
Death 578 19.5% 578 19
Fall 249 8.4% 158 56
Osteonecrosis of jaw 242 8.2% 3 79
Dyspnoea 229 7.7% 139 59
Dizziness 224 7.6% 141 54
Diarrhoea 211 7.1% 146 33
Arthralgia 207 7.0% 146 30
Nausea 203 6.9% 145 8
Fatigue 193 6.5% 149 21
Pyrexia 179 6.0% 121 35
Vomiting 172 5.8% 127 15
Asthenia 168 5.7% 129 14
Headache 163 5.5% 130 9
Sepsis 162 5.5% 153 12
Haemorrhagic stroke 158 5.3% 158 1

Other Indications for IBANDRONIC ACID

Product used for unknown indication (1,103) Osteoporosis (820) Metastases to bone (138) Breast cancer (98) Breast cancer metastatic (81) Osteopenia (78) Cancer pain (29) Plasma cell myeloma (24) Invasive ductal breast carcinoma (21) Prophylaxis (14)

Other Drugs Used for Osteoporosis postmenopausal

DENOSUMAB (18,350) ABALOPARATIDE (7,932) PROLIA (1,775) ROMOSOZUMAB-AQQG (1,401) TERIPARATIDE (263) ALENDRONATE (262) ZOLEDRONIC ACID (225) ALENDRONATE\CHOLECALCIFEROL (135) ALENDRONIC ACID (105) RISEDRONATE (105)

Related Pages

IBANDRONIC ACID Full Profile All Osteoporosis postmenopausal Drugs IBANDRONIC ACID Demographics IBANDRONIC ACID Timeline